Intrathecal Drug Delivery System Market By Offering (Pump, Catheter, Trays & Kits, and Others); By Type (Pain Management (Malignant & Non-Malignant) and Spasticity Management); By Medications (Morphine, Ziconotide, Baclofen, Non-opioid medications (such as resiniferatoxin), and Others); By End User (Hospital, Clinics, Ambulatory Surgical Centers, and Others); By Clinical Indications (Chronic back & neck pain, Sciatica, Chronic abdominal pain, Failed back & neck surgery, Central nervous system, Cancer, Reflex sympathetic dystrophy or complex regional pain syndrome, and Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Intrathecal drug delivery (IDD) treatment is mainly used for reducing chronic pain, to provide comfort as well as relief to the patient. Some of the drugs used for IDD can reduce and sometimes, even eradicate dependence on oral or systemic pain medications. Through a catheter connected to a pump, an intrathecal drug delivery system can inject a drug into the spine of a patient to reduce his/her pain. In the process of drug delivery, the pump can either be an external system or a completely implanted device with a container that can be refilled after the drug has been injected into the spinal cord of patient through his/her skin. Rise in demand for improvised analgesia is propelling the growth of global intrathecal drug delivery systems market. As the use of cancer treatment drugs, such as opioids, can have adverse reactions on the body, leading to pneumonia and sedation, using intrathecal drug delivery systems avert such complications.
Investments towards technology upgrades is anticipated to boost the growth of global intrathecal drug delivery system market over the forecast period. Several companies, in the business of developing intrathecal drug delivery system, are investing in information (IT) enabled technological up-gradation of intrathecal drug delivery systems that are not just programmable, but also able to control the flow of drug into the patient's body.
Complications of intrathecal drug delivery systems including mechanical system complications, patient-specific complications, pharmacological complications, and surgical complications, is restraining the growth of global intrathecal drug delivery system market.
The COVID-19 pandemic has severely impacted the business proceedings, as well as the live of individuals around the globe. Intrathecal drug delivery system market is expected to experience considerable growth in the coming years. The gradual normalization of healthcare facilities will allow the individuals to avail treatment for pain management and spasticity management. The healthcare facilities are increasingly seeking partnership with the market participants for the supply of intrathecal drug delivery systems to cater to the patients that are suffering from pain due to malignant conditions.
Absolute Market Insights reports, the global intrathecal drug delivery system market is likely to grow at 5.2% CAGR during the 2021-2029 period, and reach a valuation of US$ 1415.96 Mn by 2029.
Intrathecal Drug Delivery System Market Revenue & Forecast, (US$ Million), 2015 – 2029
Offering Outlook:
In terms of offering, the global intrathecal drug delivery system market is classified into pump, catheter, trays & kits, and others. In 2020, the pumps segment held the larger market share and during the forecast period, this segment is expected to retain its position in the market. Intrathecal drug delivery is also known as the "pain pump" treatment. Through a small pump, this treatment delivers pain medication directly to the spinal cord of patient. Surgically placed under the abdominal skin, the pump delivers pain medication through a catheter to the area around the patient's spinal cord. Intrathecal drug delivery is used to treat pain from a variety of conditions that include chronic back pain and neck pain. They also include chronic abdominal pain, failed back surgery, failed neck surgery, sciatica, cancer sympathetic dystrophy, reflex sympathetic dystrophy or complex regional pain syndrome.
Type Outlook:
On the basis of types, global intrathecal drug delivery system market has been broadly segmented into pain management and spasticity management. The pain management segment has been further bifurcated into malignant pain management and non-malignant pain management. In 2020, the pain management segment held the largest market share in this market. Intrathecal drugs delivery is an effective pain management option for patients suffering from chronic pain and cancer pain. The delivery of drugs into the intrathecal space can provide superior analgesia as smaller doses of analgesics minimize side effects of drugs.
End User Outlook:
Based on end-users, the global intrathecal drug delivery system market is segmented into hospital, clinics, ambulatory surgical centres, and others. Ambulatory surgical centres segment is gaining traction in the global market. A proportionate increase in the availability of acute pain-management services is necessary to match the rapidly rising clinical patient load with pain issues in the ambulatory surgery setting. Ambulatory pain control often faces challenges and overcoming those challenges is important to achieve optimum pain control and prevent morbidity as well as mortality. As the perioperative pain management in the ambulatory surgery setting is becoming increasingly complex, it requires the employment of a multimodal approach, along with the interventions facilitated by ambulatory surgery pain specialists. Clinics, as the end users of intrathecal drug delivery systems, are anticipated to register highest growth rate over the forecast period.
Clinical Indications Outlook:
On the basis of clinical indications, the global intrathecal drug delivery system market has been segmented into chronic back and neck pain, sciatica, chronic abdominal pain, failed back & neck surgery, central nervous system, cancer, reflex sympathetic dystrophy or complex regional pain syndrome, and others. In 2020, the chronic back and neck pain segment occupied the largest market share. Over the years, provision of intrathecal drug delivery systems for chronic refractory nonmalignant and malignant pain has become increasingly prevalent. Cancer research centers are also using IDD to find new possibilities regarding cancer treatment and pain management.
Region Outlook:
In 2020, North America obtained the largest market share in the global intrathecal drug delivery system market. During the forecast period, Asia Pacific region is anticipated to register highest growth rate due to accelerating technological advancement and growing medical sector in countries like India, Japan, South Korea, Singapore, and China. With improving medical facilities and increasing per capita income in these countries, medical treatment for many ailments is becoming affordable.
Competitive Landscape Outlook:
The report provides both, qualitative and quantitative research of global intrathecal drug delivery system market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others. Some of the major players operating in the global intrathecal drug delivery system market are Alcyone Lifesciences, B. Braun Melsungen AG, Flowonix, Medtronic, Smiths Group PLC, and Tricumed Medizintechnik GmbH.
Global Intrathecal Drug Delivery System Market:
By Offering
- Pump
- Catheter
- Trays and Kits
- Others
By Type
- Pain Management
- Malignant
- Non-Malignant
- Spasticity Management
By End user
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
By Medications
- Morphine
- Ziconotide
- Baclofen
- Non-opioid medications, such as resiniferatoxin
- Others
By Clinical Indications
- Chronic back and neck pain
- Sciatica
- Chronic abdominal pain
- Failed back and neck surgery
- Central nervous system
- Cancer
- Reflex sympathetic dystrophy or complex regional pain syndrome
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Intrathecal Drug Delivery System Market
6. Market Synopsis:
Intrathecal Drug Delivery System Market
7. Intrathecal Drug Delivery System Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Intrathecal Drug Delivery System Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Intrathecal Drug
Delivery System Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Intrathecal Drug Delivery System Market
8. Global Intrathecal Drug Delivery System Market Analysis and
Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global Intrathecal Drug Delivery System Market Revenue (US$
Mn)
8.2. Global Intrathecal Drug Delivery System Market Revenue (US$
Mn) and Forecasts, By Offering
8.2.1. Pump
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Catheter
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.2.3. Trays and Kits
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2020
8.2.3.3. Market Forecast, 2021 - 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2020
8.2.3.5.1.2. Market
Forecast, 2021 - 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2020
8.2.3.5.2.2. Market
Forecast, 2021 - 2029
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2020
8.2.3.5.3.2. Market
Forecast, 2021 - 2029
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2020
8.2.3.5.4.2. Market
Forecast, 2021 - 2029
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2020
8.2.3.5.5.2. Market
Forecast, 2021 - 2029
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2020
8.2.4.3. Market Forecast, 2021 - 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2020
8.2.4.5.1.2. Market
Forecast, 2021 - 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2020
8.2.4.5.2.2. Market
Forecast, 2021 - 2029
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2020
8.2.4.5.3.2. Market
Forecast, 2021 - 2029
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2020
8.2.4.5.4.2. Market
Forecast, 2021 - 2029
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2020
8.2.4.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Offering
9. Global Intrathecal Drug Delivery System Market Analysis and
Forecasts, 2021 – 2029
9.1. Overview
9.2. Global Intrathecal Drug Delivery System Market Revenue (US$
Mn) and Forecasts, By Type
9.2.1. Pain Management (Definition, Market Estimation and
Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast
(2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Malignant, Non-Malignant)
9.2.1.1. Malignant
9.2.1.2. Non-Malignant
9.2.2. Spasticity Management
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By Type
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
